Aclaris Therapeutics (ACRS) Non Operating Income (2015 - 2026)

Aclaris Therapeutics' Non Operating Income history runs 12 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 21.04% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $10.8 million (changed 0.5% YoY), while the FY2025 annual figure was $11.5 million, up 16.06% from the prior year.
• Non Operating Income was $2.4 million for Q1 2026 at Aclaris Therapeutics, down from $2.9 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.1 million in Q4 2024 to a low of $118000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $2.1 million across 5 years, with a median of $2.2 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Non Operating Income jumped 1522.47% in 2022, then fell 21.04% in 2026.
• A 5-year view of Non Operating Income shows it stood at $1.4 million in 2022, then soared by 51.59% to $2.2 million in 2023, then soared by 42.67% to $3.1 million in 2024, then slipped by 5.89% to $2.9 million in 2025, then slipped by 19.43% to $2.4 million in 2026.
• The last three Non Operating Income figures came in at $2.4 million (Q1 2026), $2.9 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.